BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/2/2022 12:11:47 PM | Browse: 747 | Download: 1876
 |
Received |
|
2021-12-13 07:31 |
|
Peer-Review Started |
|
2021-12-13 07:33 |
|
First Decision by Editorial Office Director |
|
2022-01-23 06:34 |
|
Return for Revision |
|
2022-01-23 06:34 |
|
Revised |
|
2022-02-01 10:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-04-20 02:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-04-25 19:54 |
|
Articles in Press |
|
2022-04-25 19:54 |
|
Edit the Manuscript by Language Editor |
|
2022-04-13 04:10 |
|
Typeset the Manuscript |
|
2022-05-20 08:19 |
|
Publish the Manuscript Online |
|
2022-06-02 12:11 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Serological biomarkers for management of primary sclerosing cholangitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos and Maria Papp |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund |
138041 |
| EFOP projects co-financed by the European Union and the European Social Fund |
EFOP-3.6.1-16-2016-00022 |
|
| Corresponding Author |
Maria Papp, DSc, FEBG, MD, PhD, Full Professor, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt, Debrecen H-4032, Hajdu-Bihar, Hungary. papp.maria@med.unideb.hu |
| Key Words |
Primary sclerosing cholangitis; Hepatobiliary; Serological biomarker; Immunoglobulin; Inflammatory; Tissue remodeling |
| Core Tip |
Recent advances in biomarker research may help clinicians identify relevant subgroups of primary sclerosing cholangitis (PSC) and assist everyday clinical work-up. However, a diagnostic biomarker is still an unmet need. On the other hand, several biomarkers have been reported to predict outcome in PSC; however, most of them have not been validated by subsequent studies. The IgA type anti-glycoprotein 2 antibody is the first one to be supported by a satisfactory number of clinical studies and could be incorporated into clinical practice. These discoveries also reveal different aspects of PSC providing with potential therapeutic targets. |
| Publish Date |
2022-06-02 12:11 |
| Citation |
Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i21/2291.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i21.2291 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
